Description
Trastuzumab injection is a targeted monoclonal antibody used to treat HER2-positive breast and gastric cancers. It binds to the HER2 receptor, inhibiting tumor growth and enhancing immune response. Often combined with chemotherapy, it significantly improves survival and disease-free outcomes in eligible patients.